Computerized dynamic voltammetric detection in high-performance liquid chromatography. I: On-line cyclic voltammetry of the antineoplastic agents etoposide and teniposidePLOEGMAKERS, H. H. J. L; MERTENS, M. J. M; VAN OORT, W. J et al.Analytica chimica acta. 1985, Vol 174, pp 71-82, issn 0003-2670Article

Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-dimethyl-1-O-(4,6-O-2-thenylidene-β-D-glucopyranosyl)epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumorsSTEWART, D. J; GRAHOVAC, Z; VANDENBERG, T et al.Neurosurgery. 1984, Vol 15, Num 6, pp 828-833, issn 0148-396XArticle

Seasonal Variations in the Deoxypodophyllotoxin Content and Yield of Anthriscus sylvestris L. (Hoffm.) Grown in the Field and under Controlled ConditionsHENDRAWATI, Oktavia; WOERDENBAG, Herman J; HILLE, Jacques et al.Journal of agricultural and food chemistry (Print). 2011, Vol 59, Num 15, pp 8132-8139, issn 0021-8561, 8 p.Article

Influence of teniposide on platelet functions in vitroKUBISZ, P; SEGHIER, F; DOBROTORA, M et al.Thrombosis research. 1995, Vol 77, Num 2, pp 145-148, issn 0049-3848Article

Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cellsBAKHEET, S. A; ATTIA, S. M; AL-RASHEED, N. M et al.Mutagenesis. 2011, Vol 26, Num 4, pp 533-543, issn 0267-8357, 11 p.Article

Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-β-d-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-β-d-glucopyranoside) and their metabolites on human leukemic lymphoblasts = Effets cytotoxiques et cytocinétiques comparatifs des épipodophyllotoxines, 4'-déméthylépipodophyllotoxine-9-(4,6-O-2-éthylène-bêta-D-glucopyranoside) et 4'-déméthylépipodophyllotoxine-94,6-O-2-thénylidène-bêta-D-glucopyranosid et leurs métabolites sur les lymphoblastes leucémiques humainsDOW, L. W; SINKULE, J. A; LOOK, A. T et al.Cancer research (Baltimore). 1983, Vol 43, Num 12, pp 5699-5706, issn 0008-5472Article

Réaction de type anaphylactique après administration de téniposide : prudence chez les sujets atopiques = Anaphylactoid reaction to teniposide. Caution is warrarted in atopic patientsBAUDUER, F; DELMER, A; N'ZILA IBIASSI, J. P et al.La Semaine des hôpitaux de Paris. 1993, Vol 69, Num 29, pp 879-880, issn 0037-1777Article

The effect of etoposide and teniposide on monocyte phagocytosis of yeast cellsATHLIN, L; DOMELLOF, L; NORBERG, B et al.Current therapeutic research. 1987, Vol 42, Num 3, pp 534-540, issn 0011-393XArticle

Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder = Association de cis-platine et de VM-26 dans le traitement des cancers avancés à cellules transitionnelles de la vessieSTOTER, G; VAN OOSTEROM, A. T; MULDER, J. H et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 3, pp 315-317, issn 0277-5379Article

INTERNATIONAL SYMPOSIUM ON THE PODOPHYLLOTOXINS IN CANCER THERAPY, SOUTHAMPTON, ENGLAND, JULY 8-9, 1981CARTER SK ED; MATHE G ED; MCELWAIN T ED et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 7; NO 2-3; 163 P.; BIBL. DISSEM.Conference Paper

Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male miceATTIA, Sabry M.Mutagenesis. 2012, Vol 27, Num 1, pp 31-39, issn 0267-8357, 9 p.Article

Antitumor properties of podophyllotoxin and related compoundsM.GORDALIZA; CASTRO, M. A; DEL CORRAL, J. M et al.Current pharmaceutical design. 2000, Vol 6, Num 18, pp 1811-1839, issn 1381-6128Article

Überempfindlichkeitsreaktion gegen VM-26 = Hypersensibilité à VM-26 = Hypersensitivity VM-26KÖSTER, B; RITTER, J; BODE, U et al.Klinische Pädiatrie. 1984, Vol 196, Num 3, pp 178-180, issn 0300-8630Article

Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavageROSS, W; ROWE, T; GLISSON, B et al.Cancer research (Baltimore). 1984, Vol 44, Num 12, pp 5857-5860, issn 0008-5472, 1Article

Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposideTOFFOLI, G; SORIO, R; GIGANTE, M et al.British journal of cancer. 1997, Vol 75, Num 5, pp 715-721, issn 0007-0920Article

Uptake and binding of teniposide (VM26) in Krebs II ascites cellsMOHAMED HAMZA; CANAL, P; BUGAT, R et al.Biochemical pharmacology. 1987, Vol 36, Num 10, pp 1599-1603, issn 0006-2952Article

Chemical Stability of Teniposide in Aqueous and Parenteral Lipid EmulsionsJING WANG; YUE CUI; XING TANG et al.Drug development and industrial pharmacy. 2009, Vol 35, Num 4, pp 508-513, issn 0363-9045, 6 p.Article

Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipLONG, B. H; MUSIAL, S. T; BRATTAIN, M. G et al.Biochemistry (Easton). 1984, Vol 23, Num 6, pp 1183-1188, issn 0006-2960Article

Nonintercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase IICHEN, G. L; LIU YANG; ROWE, T. C et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 21, pp 13560-13566, issn 0021-9258Article

Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26)WERKHOVEN-GOEWIE, C. E; BRINKMAN, U. A. T; FREI, R. W et al.Journal of chromatography. 1983, Vol 276, Num 2, pp 349-357, issn 0021-9673Article

Podophyllotoxin derivatives VP-16 and VM-26D'INCALCI, M; GARATTINI, S.Cancer chemotherapy. 1983, Num 5, pp 100-106Article

PODOPHYLLOTOXIN DERIVATIVES VP-16 AND VM-26D'INCALCI M; GARATTINI S.1982; CANCER CHEMOTHERAPY; ISSN 505242; NLD; DA. 1982; NO 4; PP. 87-94; BIBL. 57 REF.Article

CYTOFLUOROMETRIC STUDIES ON THE ACTION OF PODOPHYLLOTOXIN AND EPIPODOPHYLLOTOXINS (VM-26, VP-16-213) ON THE CELL CYCLE TRAVERSE OF HUMAN LYMPHOBLASTS. = ETUDES CYTOFLUORIMETRIQUES SUR L'ACTION DE LA PODOPHYLLOTOXINE ET DES EPIPODOPHYLLOTOXINES (VM-26, VP-16-213) SUR LE DEROULEMENT DU CYCLE CELLULAIRE DES LYMPHOBLASTES HUMAINSKRISHAN A; PAIKA K; FREI E III et al.1975; J. CELL BIOL.; U.S.A.; DA. 1975; VOL. 66; NO 3; PP. 521-530; BIBL. 25 REF.Article

RESPONSE OF L1210 TO COMBINATIONS OF CYTOSINE ARABINOSIDE AND VM-26 OR VP16-213. = REPONSE DE L1210 A DES TRAITEMENTS COMBINES CYTOSINE ARABINOSIDE+VM-26 OU +VP16-213RIVERA G; AVERY T; ROBERTS D et al.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 9; PP. 639-647; BIBL. 1 P. 1/2Article

VM 26-INDUCED CHANGES IN HEPATIC INTERMEDIARY METABOLISM OF MICE.HACKER M; ROBERTS D.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 9; PP. 3287-3292; BIBL. 9 REF.Article